Alfred Hermann Böcking

Prof. Dr. Alfred Hermann Böcking


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Pathology Discovery
Verified
Journal Article
Open access
PDF file
ABAlfred Hermann Böcking
Alfred Hermann Böcking
MTMaurits Tils
Maurits Tils
MSMartin Schramm
Martin Schramm
JDJosef Dietz
Josef Dietz
SBStefan Biesterfeld
Stefan Biesterfeld
Gleason-score <=6, assessed on core needle biopsies, is an essential prognostic parameter to offer the strategy of Active Surveillance (AS) to patients with locally confined cancers of the prostate. Yet, its interobserver

30 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ABAlfred Hermann Böcking
Alfred Hermann Böcking
DFDavid Friedrich
David Friedrich
MSMartin Schramm
Martin Schramm
BPBranko Palcic
Branko Palcic
GEGregor Erbeznik
Gregor Erbeznik
Background: Microscopical screening of cytological samples for the presence of cancer cells at high throughput with sufficient diagnostic accuracy requires highly specialized personnel which is not available in most countries. Methods: Using commercially available automated microscope-based screeners (MotiCyte and EasyScan), software was developed which is able to classify Feulgen-stained nuclei into eight diagnostically relevant types, using supervised machine learning. the nuclei belonging to normal cells were used for internal calibration of the nuclear DNA content while nuclei belonging to those suspicious of being malignant were specifically identified. The percentage of morphologically abnormal nuclei was used to identify samples suspected of malignancy, and the proof of DNA-aneuploidy was used to definitely determine the state malignancy. A blinded study was performed using oral smears from 92 patients with Fanconi anemia, revealing oral leukoplakias or erythroplakias. In an earlier study, we compared diagnostic accuracies on 121 serous effusion specimens. In addition, using a blinded study employing 80 patients with prostate cancer who were under active surveillance, we aimed to identify those whose cancers would not advance within 4 years. Results: Applying a threshold of the presence of >4% of morphologically abnormal nuclei from oral squamous cells and DNA single-cell or stemline aneuploidy to identify samples suspected of malignancy, an overall diagnostic accuracy of 91.3% was found as compared with 75.0% accuracy determined by conventional subjective cytological assessment using the same slides. Accuracy of automated screening effusions was 84.3% as compared to 95.9% of conventional cytology. No prostate cancer patients under active surveillance, revealing DNA-grade 1, showed progress of their disease within 4.1 years. Conclusions: An automated microscope-based screener was developed which is able to identify malignant cells in different types of human specimens with a diagnostic accuracy comparable with subjective cytological assessment. Early prostate cancers which do not progress despite applying any therapy could be identified using this automated approach.

19 October 2018 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
ABAlfred Hermann Böcking
Alfred Hermann Böcking
DFDavid Friedrich
David Friedrich
DMDietrich Meyer‐Ebrecht
Dietrich Meyer‐Ebrecht
CZChenyan Zhu
Chenyan Zhu
AFAnna Feider
Anna Feider
SBStefan Biesterfeld
Stefan Biesterfeld
BACKGROUND The average sensitivity of conventional cytology for the identification of cancer cells in effusion specimens is only approximately 58%. DNA image cytometry (DNA‐ICM), which exploits the DNA content of morphologically suspicious nuclei measured on digital images, has a sensitivity of up to 91% for the detection of cancer cells. However, when performed manually, to our knowledge to date, an expert needs approximately 60 minutes for the analysis of a single slide. METHODS In the current study, the authors present a novel method of supervised machine learning for the automated identification of morphologically suspicious mesothelial and epithelial nuclei in Feulgen‐stained effusion specimens. The authors compared this with manual DNA‐ICM and a gold standard cytological diagnosis for 121 cases. Furthermore, the authors retrospectively analyzed whether the amount of morphometrically abnormal mesothelial or epithelial nuclei detected by the digital classifier could be used as an additional diagnostic marker. RESULTS The presented semiautomated DNA karyometric solution identified more diagnostically relevant abnormal nuclei compared with manual DNA‐ICM, which led to a higher sensitivity (76.4% vs 68.5%) at a specificity of 100%. The ratio between digitally abnormal and all mesothelial nuclei was found to identify cancer cell–positive slides at 100% sensitivity and 70% specificity. The time effort for an expert therefore is reduced to the verification of a few nuclei with exceeding DNA content, which to our knowledge can be accomplished within 5 minutes. CONCLUSIONS The authors have created and validated a computer‐assisted bimodal karyometric approach for which both nuclear morphology and DNA are quantified from a Feulgen‐stained slide. DNA karyometry thus increases the diagnostic accuracy and reduces the workload of an expert when compared with manual DNA‐ICM.

18 April 2015 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
ABAlfred Hermann Böcking
Alfred Hermann Böcking
Knowledge of the karyotypes of cancer cells is the theoretical underpinning of diagnostic/prognostic DNA-cytometry. Currently the translation is hampered by different terminologies of both fields. The following letter tries to close current gaps between the two fields by harmonizing their different terminologies.

26 August 2015 in Der Pathologe
Verified
Journal Article
Closed access
PDF file
ABAlfred Hermann Böcking
Alfred Hermann Böcking
SBS. Biesterfeld
S. Biesterfeld
JDJ. Dietz
J. Dietz
GHG. Haroske
G. Haroske
JKJ. Kriegsmann
J. Kriegsmann
SFS. Falk
S. Falk

14 June 2024 in Deutsches Ärzteblatt international
Verified
Journal Article
Closed access
ABAlfred Hermann Böcking
Alfred Hermann Böcking
VSVolker Siller
Volker Siller